Status:
COMPLETED
Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)
Lead Sponsor:
Organon and Co
Conditions:
Asthma, Exercise-Induced
Eligibility:
All Genders
15-45 years
Phase:
PHASE3
Brief Summary
To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exerc...
Eligibility Criteria
Inclusion
- Physician-diagnosed exercise-induced bronchospasm
Exclusion
- Patient is, other than asthma, not in good, stable health. The Primary Investigator will evaluate whether there are other reasons why the patient may not participate.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00245570
Start Date
December 1 2005
End Date
September 1 2006
Last Update
February 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.